Doctoral School of Medicine and Pharmacy, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 540142 Targu Mures, Romania.
2nd Department of Surgery, Mures County Emergency Hospital, 540136 Targu Mures, Romania.
Medicina (Kaunas). 2024 Nov 1;60(11):1789. doi: 10.3390/medicina60111789.
Overweight and obesity are well-known conditions that negatively impact the health and lifestyle of an individual. Bariatric surgery is one of the most efficient weight loss techniques. Besides the main effect on the bodyweight, improvement in the levels of inflammatory biomarkers, such as interleukin 6 (IL-6), tumor necrosis factor alpha (TNFalfa), and others, has been observed. The purpose of this study was to establish the correlations between obesity-linked chronic systemic inflammation (estimated with inflammatory cytokine levels) and the weight loss process after metabolic surgery. An observational cohort study included two categories: the patients with obesity-bariatric group and the patients without obesity-control group. The study was performed between 1 February 2021 and 1 March 2023. Baseline characteristics, anthropometrics, biochemical assessment and inflammatory biomarkers were measured both before surgery and one year after the procedure, in the case of the bariatric group. The control group was assessed in the same period as the pre-surgery bariatric group. The bariatric group underwent two types of bariatric procedures: the majority underwent laparoscopic sleeve gastrectomy whereas a select few underwent one anastomosis laparoscopic gastric bypass. We performed a prospective study comprising 55 Caucasian patients-from which 33 patients had morbid obesity, a mean age of 41.76 ± 10.78 and a mean BMI of 43.34± 7.51 kg/m. The preoperative levels of IL-6 were positively correlated with waist circumference (r = 0.354, = 0.043), weight (r = 0.549, = 0.001) and BMI (r = 0.520, = 0.002). After applying the Kruskal-Wallis test and Dunn's test, significant differences for IL-6 ( = 0.010) and adiponectin ( = 0.024) were obtained for values recorded pre- and post-surgery. No correlation was found between adiponectin, IL-6, TNF- α levels and anthropometric indices after surgery. Our study showed that bariatric surgery significantly changes the values of inflammatory cytokines one year after surgery. Nevertheless, we did not find significant correlations between the baseline values of these inflammatory markers and the weight loss process after surgery at a short-term (one-year) follow-up. Our study demonstrated that bariatric surgery significantly changes the level of inflammatory cytokines one year after operation. We demonstrate that preoperative levels of IL-6 are positively correlated with age, WC, and BMI.
超重和肥胖是众所周知的会对个人健康和生活方式产生负面影响的情况。减重手术是最有效的减肥技术之一。除了对体重的主要影响外,还观察到炎症生物标志物水平的改善,如白细胞介素 6 (IL-6)、肿瘤坏死因子-α (TNFalfa) 等。本研究的目的是建立肥胖相关慢性系统性炎症(用炎症细胞因子水平估计)与代谢手术后体重减轻过程之间的相关性。
肥胖-减重组患者和无肥胖-对照组患者。该研究于 2021 年 2 月 1 日至 2023 年 3 月 1 日进行。在减重组中,分别在手术前和手术后一年测量基线特征、人体测量学、生化评估和炎症生物标志物。对照组在与术前减重组相同的时期进行评估。减重组接受了两种减重手术:大多数患者接受腹腔镜袖状胃切除术,少数患者接受单吻合口腹腔镜胃旁路术。
我们进行了一项前瞻性研究,包括 55 名高加索患者-其中 33 名患者患有病态肥胖,平均年龄为 41.76±10.78 岁,平均 BMI 为 43.34±7.51kg/m。术前 IL-6 水平与腰围(r = 0.354, = 0.043)、体重(r = 0.549, = 0.001)和 BMI(r = 0.520, = 0.002)呈正相关。应用 Kruskal-Wallis 检验和 Dunn 检验后,IL-6( = 0.010)和脂联素( = 0.024)的术前和术后记录值差异显著。手术后,脂联素、IL-6、TNF-α 水平与人体测量指数之间未发现相关性。我们的研究表明,减重手术后一年,炎症细胞因子的值发生了显著变化。然而,在短期(一年)随访中,我们没有发现这些炎症标志物的基线值与手术后的体重减轻过程之间存在显著相关性。
我们的研究表明,减重手术后一年,炎症细胞因子的水平发生了显著变化。我们证明术前 IL-6 水平与年龄、WC 和 BMI 呈正相关。